|
ZUFSP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.529800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.382000E-01 |
| Normal-vs-Stage2 |
8.660400E-01 |
| Normal-vs-Stage3 |
6.643600E-01 |
| Normal-vs-Stage4 |
3.423600E-01 |
| Stage1-vs-Stage2 |
4.768200E-01 |
| Stage1-vs-Stage3 |
2.787200E-01 |
| Stage1-vs-Stage4 |
8.116800E-01 |
| Stage2-vs-Stage3 |
8.539200E-01 |
| Stage2-vs-Stage4 |
5.029800E-01 |
| Stage3-vs-Stage4 |
4.182800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.377780E-01 |
| Normal-vs-AfricanAmerican |
2.397400E-01 |
| Normal-vs-Asian |
9.465400E-01 |
| Caucasian-vs-AfricanAmerican |
1.832320E-02 |
| Caucasian-vs-Asian |
6.091800E-01 |
| AfricanAmerican-vs-Asian |
6.946400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.791560E-01 |
| Normal-vs-Female |
4.445600E-01 |
| Male-vs-Female |
3.146400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.087600E-01 |
| Normal-vs-Extreme_Weight |
2.219800E-02 |
| Normal-vs-Obese |
8.048800E-01 |
| Normal-vs-Extreme_Obese |
8.283600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.585400E-01 |
| Normal_Weight-vs-Obese |
4.114200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.268000E-01 |
| Extreme_Weight-vs-Obese |
1.964480E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.800800E-01 |
| Obese-vs-Extreme_Obese |
7.060800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.032400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.395400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.501250E-01 |
| Normal-vs-Age(81-100Yrs) |
2.740800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.794600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.386300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.563200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.882000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.379900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.536190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.723000E-01 |
| Normal-VS-Type2 PRCC |
3.892000E-01 |
| Normal-VS-KIRP CIMP |
2.459200E-01 |
| Normal-VS-Unclassified PRCC |
1.559170E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.039600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.236000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.312400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.779800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.256800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.239960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.095500E-02 |
| Normal-vs-N1 |
1.157210E-01 |
| Normal-vs-N2 |
2.568600E-01 |
| N0-vs-N1 |
1.722770E-03 |
| N0-vs-N2 |
3.413800E-01 |
| N1-vs-N2 |
5.221600E-02 |
|
|
